Advertisement
Screener

Tilray Brands, Inc. (TLRY) Short-term Debt

2.8 / 5 stars · 68/120 Roast Me

Tilray Brands, Inc. Short-term Debt

Tilray Brands, Inc. (TLRY) had Short-term Debt of $8.78 million as of 2026-05-31, per its 10-K filed 2026-07-28.

Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Debt, Current

us-gaap:ShortTermBorrowings · last filed 2026-07-28

  • 2026-05-31: Short-term Debt $8.78M.
  • 2026-02-28: Short-term Debt $8.83M.
  • 2025-12-31: Short-term Debt $7.18M.
  • 2025-11-30: Short-term Debt $8.57M.
Period endShort-term Debt
2026-05-31$8.78M
10-K · filed 2026-07-28
2026-02-28$8.83M
10-Q · filed 2026-04-01
2025-12-31$7.18M
10-K · filed 2026-07-28
2025-11-30$8.57M
10-Q · filed 2026-01-08
2025-08-31$8.19M
10-Q · filed 2025-10-09
2025-05-31$7.18M
10-Q · filed 2026-04-01
2024-12-31$10.74M
10-Q · filed 2025-04-08
2024-11-30$17.75M
10-Q · filed 2025-01-10
2024-08-31$18.13M
10-Q · filed 2024-10-10
2024-05-31$18.03M
10-K · filed 2025-07-29
2024-02-29$15.03M
10-Q · filed 2024-04-09
2023-12-31$18.03M
10-Q · filed 2025-04-08
2023-11-30$20.18M
10-Q · filed 2024-01-09
2023-08-31$14.59M
10-Q · filed 2024-10-10
2023-05-31$23.38M
10-Q · filed 2024-10-10
2023-02-28$18.13M
10-Q · filed 2023-04-10
2022-11-30$15.30M
10-Q · filed 2023-01-09
2022-08-31$18.28M
10-Q · filed 2022-10-07
2022-05-31$18.12M
10-K · filed 2023-07-26
2022-03-31$18.12M
10-Q · filed 2023-01-09
2022-02-28$17.50M
10-Q · filed 2022-04-06
2021-11-30$8.74M
10-Q · filed 2022-01-10
2021-08-31$9.20M
10-Q · filed 2021-10-07
2021-05-31$8.72M
10-K · filed 2022-07-28
2020-05-31$389.00K
10-K · filed 2021-07-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
Canopy Growth Corp (CGC)$0.395B
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
Niagen Bioscience, Inc. (NAGE)United States$0.238B15.72
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
MANNATECH INC (MTEX)United States$0.014B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
Synergy CHC Corp. (SNYR)United States$0.001B
Functional Brands Inc. (MEHA)United States$0.001B
Cronos Group Inc. (CRON)$1.223B
Definium Therapeutics, Inc. (DFTX)United States$4.931B-17.87